Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

futibatinib × Lymphoid × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Plasma cell 1 Lymphoid 1

Conditions

Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 81 Rituximab 78 Specimen Handling 56 venetoclax 46 Magnetic Resonance Spectroscopy 46 Biopsy 46 Vincristine 42 Prednisone 41 Doxorubicin 38 fludarabine 37 obinutuzumab 30 Lenalidomide 30 ibrutinib 25 fludarabine phosphate 21 Cytarabine 20 CT-P10 20 Methotrexate 19 Etoposide 19 glofitamab 18 deltacortene 17 prednylidene 16 Bendamustine Hydrochloride 16 zanubrutinib 15 blinatumomab 14 Dexamethasone 14 Gemcitabine 13 Prednisolone 12 Granulocyte Colony-Stimulating Factor 12 pirtobrutinib 11 Spinal Puncture 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02693535 2026-03-19

TAPUR

American Society of Clinical Oncology

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡